NHS Reports 100 Weekly Cancers Found in 50s Bowel Screening

Participation in bowel cancer screening among people in their fifties remains lower than health officials would like, according to newly released NHS England data. The figures, covering the period from April 2024 to March 2025, indicate that only 56.2% of 54-year-olds returned their faecal immunochemical test kits. This rate sits below the uptake seen in older age groups, prompting a renewed call for eligible individuals to complete the simple at-home test.

Uptake gap in the youngest eligible cohort

Bowel screening is currently offered to everyone aged 54 to 74 in England, with the programme gradually expanding to include people from the age of 50. The latest statistics highlight a particular drop-off at the entry point. While participation tends to increase with age, the 56.2% figure for 54-year-olds represents the lowest return rate within the screened population. NHS England described the trend as a concern, given the programme’s capacity to detect malignancies early, often before symptoms appear.

Across the full cohort of people in their fifties, the screening programme finds approximately 100 cancers each week. These detections frequently occur at an early stage, when treatment is more likely to be effective. The test works by identifying tiny traces of blood in stool samples, which can be an early sign of bowel cancer or precancerous polyps.

How the programme works

Eligible individuals receive a kit through the post every two years. The test requires a small stool sample, which is then returned to a laboratory for analysis. Results are typically sent back within two weeks. If blood is detected, the person is invited for further investigation, usually a colonoscopy, to determine the cause. The entire process is designed to be convenient and private, removing barriers that might deter participation.

Despite the straightforward nature of the test, uptake has historically lagged among men, people from lower-income backgrounds, and some ethnic minority groups. The new data on 54-year-olds adds a demographic dimension to these known disparities. NHS England did not speculate on the reasons for lower participation at this age but emphasised the importance of returning the kit promptly.

Early detection and survival

Bowel cancer is the fourth most common cancer in the UK, with around 43,000 new diagnoses each year. Survival depends heavily on the stage at diagnosis. When caught at stage one, more than 90% of patients survive for at least five years. Late-stage diagnosis reduces that figure sharply. Screening programmes aim to shift diagnoses toward earlier stages, and the NHS has previously reported that the faecal immunochemical test is more sensitive and easier to use than the older guaiac-based test it replaced.

The statistic of 100 cancers detected weekly among people in their fifties underscores the programme’s impact. Without screening, many of these cases would likely progress unnoticed until symptoms develop, by which point treatment options may be more limited. NHS England noted that the test can also prevent cancer by identifying polyps that can be removed before they become malignant.

Context and next steps

The bowel screening programme in England has undergone significant changes in recent years, including the lowering of the starting age from 60 to 50 in a phased rollout. The inclusion of 54-year-olds is part of that expansion. NHS England continues to monitor uptake closely and has run public awareness campaigns to encourage participation. The latest figures serve as a benchmark for those efforts.

While the 56.2% participation rate represents a majority, it leaves a substantial minority unscreened. Health officials have previously pointed to the cumulative effect of missed screenings: each round that is skipped increases the window during which a cancer could develop undetected. The programme’s two-year cycle is designed to balance sensitivity with practicality, but its effectiveness depends on consistent participation.

NHS England’s data release did not include regional breakdowns or comparisons with previous years for the specific 54-year-old cohort, but the overall trend in screening uptake has been one of gradual improvement since the introduction of the faecal immunochemical test. The focus on people in their fifties reflects both the expansion of eligibility and the recognition that establishing a screening habit early may improve long-term adherence.